An Insight into the Prospects and Drawbacks of Stem Cell Therapy for Spinal Cord Injuries: Ongoing Trials and Future Directions

被引:7
作者
Khan, Shahidul Islam [1 ]
Ahmed, Nazmin [2 ]
Ahsan, Kamrul [1 ]
Abbasi, Mahmud [3 ]
Maugeri, Rosario [4 ]
Chowdhury, Dhiman [5 ]
Bonosi, Lapo [4 ]
Brunasso, Lara [4 ]
Costanzo, Roberta [4 ]
Iacopino, Domenico Gerardo [4 ]
Umana, Giuseppe Emmanuele [6 ]
Chaurasia, Bipin [7 ]
机构
[1] Bangabandhu Sheikh Mujib Med Univ, Dept Orthopaed Surg, Spine Surg Unit, Dhaka 1000, Bangladesh
[2] Ibrahim Cardiac Hosp & Res Inst, Dept Neurosurg, Dhaka 1000, Bangladesh
[3] Ibrahim Cardiac Hosp & Res Inst, Dept Gen Anaesthesiol, Dhaka 1000, Bangladesh
[4] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Post Grad Residency Program Neurol Surg, Neurosurg Clin,AOUP Paolo Giaccone,Sch Med, I-90133 Palermo, Italy
[5] Bangabandhu Sheikh Mujib Med Univ, Dept Neurosurg, Dhaka 1000, Bangladesh
[6] Cannizzaro Hosp, Trauma Ctr, Gamma Knife Ctr, Dept Neurosurg, I-95126 Catania, Italy
[7] Neurosurg Clin, Dept Neurosurg, Birgunj 44300, Nepal
关键词
spinal cord injury; stem cells; stem cell therapy; clinical trials; MESENCHYMAL STROMAL CELLS; REPEATED SUBARACHNOID ADMINISTRATIONS; PHASE-I; TRANSPLANTATION; 1ST-IN-HUMAN; TECHNOLOGY; PROMISE; SAFETY;
D O I
10.3390/brainsci13121697
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Spinal cord injury (SCI) is a devastating neurological disorder that has a substantial detrimental impact on a person's quality of life. The estimated global incidence of SCI is 40 to 80 cases per million people and around 90% of cases are traumatic. Various etiologies can be recognized for SCI, and post-traumatic SCI represents the most common of these. Patients worldwide with SCI suffer from a persistent loss of motor and sensory function, which affects every aspect of their personal and social lives. Given the lack of effective treatments, many efforts have been made to seek a cure for this condition. In recent years, thanks to their ability to regenerate tissue and repair lost or damaged cells, much attention has been directed toward the use of stem cells (embryonic, induced pluripotent, mesenchymal, hematopoietic), aimed at restoring the functional integrity of the damaged spinal cord and improving a functional recovery including sensory and motor function. In this paper, we offer an overview of the benefits and drawbacks of stem cell therapy for SCI based on clinical evidence. This report also addresses the characteristics of various stem cell treatments, as well as the field's likely future. Each cell type targets specific pathological characteristics associated with SCI and demonstrates therapeutic effects via cell replacement, nutritional support, scaffolds, and immunomodulation pathways. SCI accompanied by complex pathological processes cannot be resolved by single treatment measures. Stem cells are associated with the adjustment of the expression of neurotrophic factors that help to achieve better nutrition to damaged tissue. Single-cell treatments have been shown in some studies to provide very minor benefits for SCI in multiple preclinical studies and a growing number of clinical trials. However, SCI damage is complex, and many studies are increasingly recognizing a combination approach such as physical therapy, electrical stimulation, or medication therapy to treatment.
引用
收藏
页数:14
相关论文
共 64 条
[1]   Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening [J].
Aboul-Soud, Mourad A. M. ;
Alzahrani, Alhusain J. ;
Mahmoud, Amer .
CELLS, 2021, 10 (09)
[2]   Transplantation of Purified Autologous Leukapheresis-Derived CD34+ and CD133+ Stem Cells for Patients With Chronic Spinal Cord Injuries: Long-Term Evaluation of Safety and Efficacy [J].
Al-Zoubi, Adeeb ;
Jafar, Emad ;
Jamous, Mohammad ;
Al-Twal, Feras ;
Al-Bakheet, Sameh ;
Zalloum, Mahasen ;
Khalifeh, Farah ;
Abu Radi, Samer ;
El-Khateeb, Mohammed ;
Al-Zoubi, Ziad .
CELL TRANSPLANTATION, 2014, 23 :S25-S34
[3]   Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study [J].
Albu, Sergiu ;
Kumuru, Hatice ;
Coll, Ruth ;
Vives, Joaquim ;
Valles, Margarita ;
Benito-Penalva, Jesus ;
Rodriguez, Luciano ;
Codinach, Margarita ;
Hernandez, Joaquim ;
Navarro, Xavier ;
Vidal, Joan .
CYTOTHERAPY, 2021, 23 (02) :146-156
[4]  
Ammar Ahmed Sabry, 2017, Asian J Neurosurg, V12, P681, DOI 10.4103/ajns.AJNS_351_16
[5]   Safety of Autologous Human Schwann Cell Transplantation in Subacute Thoracic Spinal Cord Injury [J].
Anderson, Kim D. ;
Guest, James D. ;
Dietrich, W. Dalton ;
Bunge, Mary Bartlett ;
Curiel, Rosie ;
Dididze, Marine ;
Green, Barth A. ;
Khan, Aisha ;
Pearse, Damien D. ;
Saraf-Lavi, Efrat ;
Widerstrom-Noga, Eva ;
Wood, Patrick ;
Levi, Allan D. .
JOURNAL OF NEUROTRAUMA, 2017, 34 (21) :2950-2963
[6]   Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms [J].
Anjum, Anam ;
Yazid, Muhammad Da'in ;
Fauzi Daud, Muhammad ;
Idris, Jalilah ;
Ng, Angela Min Hwei ;
Selvi Naicker, Amaramalar ;
Ismail, Ohnmar Htwe Rashidah ;
Athi Kumar, Ramesh Kumar ;
Lokanathan, Yogeswaran .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) :1-35
[7]   An allogenic therapeutic strategy for canine spinal cord injury using mesenchymal stem cells [J].
Bhat, Irfan A. ;
Sivanarayanan, T. B. ;
Somal, Anjali ;
Pandey, Sriti ;
Bharti, Mukesh K. ;
Panda, Bibhudatta S. K. ;
Indu, B. ;
Verma, Megha ;
Anand, J. ;
Sonwane, Arvind ;
Kumar, G. Sai ;
Amarpal ;
Chandra, Vikash ;
Sharma, G. Taru .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (03) :2705-2718
[8]   Stem Cell Strategies in Promoting Neuronal Regeneration after Spinal Cord Injury: A Systematic Review [J].
Bonosi, Lapo ;
Silven, Manikon Poullay ;
Biancardino, Antonio Alessandro ;
Sciortino, Andrea ;
Giammalva, Giuseppe Roberto ;
Scerrati, Alba ;
Sturiale, Carmelo Lucio ;
Albanese, Alessio ;
Tumbiolo, Silvana ;
Visocchi, Massimiliano ;
Iacopino, Domenico Gerardo ;
Maugeri, Rosario .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
[9]   CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury [J].
Bydon, Mohamad ;
Dietz, Allan B. ;
Goncalves, Sandy ;
Moinuddin, F. M. ;
Alvi, Mohammed Ali ;
Goyal, Anshit ;
Yolcu, Yagiz ;
Hunt, Christine L. ;
Garlanger, Kristin L. ;
Del Fabro, Anna S. ;
Reeves, Ronald K. ;
Terzic, Andre ;
Windebank, Anthony J. ;
Qu, Wenchun .
MAYO CLINIC PROCEEDINGS, 2020, 95 (02) :406-414
[10]   Stem Cells in the Clinic [J].
Chari, Sheila ;
Anh Nguyen ;
Saxe, Jonathan .
CELL STEM CELL, 2018, 22 (06) :781-782